Ontario at the Redefining Early Stage Investments Conference (RESI) 2024
September 25 - 27, 2024
Ontario’s medtech cluster supports a vibrant industry, innovating and developing a wide range of medical technologies used in the treatment, mitigation, diagnosis and prevention of disease. It boasts an impressive and growing diversity of companies in terms of size, focus, product and maturity level. Ontario has global-leading health research facilities and highly skilled talent, along with a stellar medtech ecosystem to support innovation that benefits patients, companies and society.
Meet Ontario's delegates to the RESI Conference 2024
Ontario is bringing 13 companies as a part of our delegation to this year’s mission.
Participants
13 in total
20/20 OptimEyes Technologies has developed a mucoadhesive drug delivery platform technology that allows for…
CanaQuest is a clinical-stage life sciences company developing innovative cannabinoid-based therapeutics. Its…
Canurta stands at the forefront of biotechnological innovation, developing new small-molecule therapeutics from…
Healthyher.Life is a women’s health navigator platform for its member community of women and gender-diverse…
Hole Medical Ltd. is a pioneering digital health aggregator at the forefront of healthcare innovation. Its…
ImmunoBiochem is an innovative biopharmaceutical company on a mission to develop novel bioconjugate therapeutics…
For over two decades, Inertia has been the trusted partner for start-ups in the medical device, diagnostic, and…
JN Nova Pharma is a Canadian biotech company collaborating with the National Research Council of…
Noa Therapeutics is a preclinical biotech company pioneering the development of homeostatic modulating small…
ProteinQure has built the best computational platform for designing peptides for extra-cellular targets. Its lead…
PurMinds is a neuro-medicine company pursuing breakthrough solutions to neurological disorders by leveraging…
QurCan Therapeutics is a biotechnology company that has developed the next-generation nanoparticle for safer and…
VeriLuce Therapeutics is an R&D/early-stage drug development company currently developing novel small…